On Monday, Oncolytics Biotech, Inc (NASDAQ: ONCY) opened lower -10.80% from the last session, before settling in for the closing price of $0.99. Price fluctuations for ONCY have ranged from $0.33 to $1.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 23.13% over the past five years. Company’s average yearly earnings per share was noted 4.08% at the time writing. With a float of $94.25 million, this company’s outstanding shares have now reached $96.60 million.
Let’s look at the performance matrix of the company that is accounted for 28 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Oncolytics Biotech, Inc (ONCY) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Oncolytics Biotech, Inc is 2.43%, while institutional ownership is 9.90%.
Oncolytics Biotech, Inc (ONCY) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.82% during the next five years compared to 23.13% growth over the previous five years of trading.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Check out the current performance indicators for Oncolytics Biotech, Inc (ONCY). In the past quarter, the stock posted a quick ratio of 3.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Oncolytics Biotech, Inc (NASDAQ: ONCY) saw its 5-day average volume 1.01 million, a positive change from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 12.97%.
During the past 100 days, Oncolytics Biotech, Inc’s (ONCY) raw stochastic average was set at 54.41%, which indicates a significant increase from 15.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1006 in the past 14 days, which was higher than the 0.0651 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7978, while its 200-day Moving Average is $0.7911.
